DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury
暂无分享,去创建一个
Jiye Shi | Hao Yan | Peng Huang | Chunhai Fan | Dalong Ni | Weibo Cai | Luhao Zhang | Zhilei Ge | Steve Y. Cho | Hyung-Jun Im | Christopher G England | Dawei Jiang | Yan Liu | Hao Yan | Jiye Shi | Yan Liu | W. Cai | C. Fan | J. Engle | Peng Huang | Zhilei Ge | Dalong Ni | H. Im | Dawei Jiang | Yongjun Yan | C. England | Steve Y Cho | Yongjun Yan | Jonathan W Engle | Junjun Hou | Christopher J Kutyreff | Chunhai Fan | Luhao Zhang | Hao Yan | C. Kutyreff | Junjun Hou | Steve Y. Cho | Peng Huang
[1] Chunhai Fan,et al. DNA Nanotechnology-Enabled Drug Delivery Systems. , 2018, Chemical reviews.
[2] Baoquan Ding,et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo , 2018, Nature Biotechnology.
[3] Hendrik Dietz,et al. Biotechnological mass production of DNA origami , 2017, Nature.
[4] Hao Yan,et al. Engineering nucleic acid structures for programmable molecular circuitry and intracellular biocomputation. , 2017, Nature chemistry.
[5] R. Jin,et al. Glomerular Barrier Behaves As an Atomically Precise Bandpass Filter in a Sub-nanometer Regime , 2017, Nature nanotechnology.
[6] David J. Mooney,et al. Oligolysine-based coating protects DNA nanostructures from low-salt denaturation and nuclease degradation , 2017, Nature Communications.
[7] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[8] Cheng Hu,et al. Eupafolin nanoparticle improves acute renal injury induced by LPS through inhibiting ROS and inflammation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] Vasilis Ntziachristos,et al. DNA‐Nanostructure–Gold‐Nanorod Hybrids for Enhanced In Vivo Optoacoustic Imaging and Photothermal Therapy , 2016, Advanced materials.
[10] O. Farokhzad,et al. Nanomedicines for renal disease: current status and future applications , 2016, Nature Reviews Nephrology.
[11] Weibo Cai,et al. DNA nanomaterials for preclinical imaging and drug delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[12] R. Hicks,et al. Gallium-68 EDTA PET/CT for Renal Imaging. , 2016, Seminars in nuclear medicine.
[13] Peng Yin,et al. Genetic encoding of DNA nanostructures and their self-assembly in living bacteria , 2016, Nature Communications.
[14] J. Chao,et al. Hetero-assembly of gold nanoparticles on a DNA origami template , 2016, Science China Chemistry.
[15] D. Scheinberg,et al. Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury , 2016, Science Translational Medicine.
[16] Shery Jacob,et al. A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.
[17] Jiye Shi,et al. Multiple-Armed Tetrahedral DNA Nanostructures for Tumor-Targeting, Dual-Modality in Vivo Imaging. , 2016, ACS applied materials & interfaces.
[18] Yusuke Suzuki,et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice , 2016, Nature Medicine.
[19] Haotian Sun,et al. A porphyrin-PEG polymer with rapid renal clearance. , 2016, Biomaterials.
[20] Jaehong Key,et al. Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors. , 2015, ACS nano.
[21] Ravikumar Arvapalli,et al. Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats , 2015, Journal of Nanobiotechnology.
[22] Yamuna Krishnan,et al. Designing DNA nanodevices for compatibility with the immune system of higher organisms. , 2015, Nature nanotechnology.
[23] Hao Yan,et al. Complex wireframe DNA origami nanostructures with multi-arm junction vertices. , 2015, Nature nanotechnology.
[24] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[25] Richard A. Muscat,et al. DNA nanotechnology from the test tube to the cell. , 2015, Nature nanotechnology.
[26] M. Eblan,et al. Clinical Translation of Nanomedicine. , 2015, Chemical reviews.
[27] D. Heller,et al. Mesoscale nanoparticles selectively target the renal proximal tubule epithelium. , 2015, Nano letters.
[28] David Binns,et al. 68Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional 51Cr-EDTA , 2015, The Journal of Nuclear Medicine.
[29] Jiye Shi,et al. Programmable engineering of a biosensing interface with tetrahedral DNA nanostructures for ultrasensitive DNA detection. , 2015, Angewandte Chemie.
[30] P. Marik. Acute Kidney Injury , 2015 .
[31] S. Siva,et al. 68 Ga-EDTA PET / CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification : Comparison to Conventional 51 Cr-EDTA , 2015 .
[32] Zhen Gu,et al. Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery , 2014, Journal of the American Chemical Society.
[33] William M. Shih,et al. Addressing the Instability of DNA Nanostructures in Tissue Culture , 2014, ACS nano.
[34] P. Kimmel,et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. , 2014, The New England journal of medicine.
[35] Qiao Jiang,et al. DNA origami as an in vivo drug delivery vehicle for cancer therapy. , 2014, ACS nano.
[36] K. Gothelf,et al. Singlet oxygen in DNA nanotechnology. , 2014, Accounts of chemical research.
[37] Jorge Cerdá,et al. Raising Awareness of Acute Kidney Injury: A Global Perspective of a Silent Killer , 2013, Kidney international.
[38] Weihong Tan,et al. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics , 2013, Proceedings of the National Academy of Sciences.
[39] Kira S. Makarova,et al. Comparative genomics of defense systems in archaea and bacteria , 2013, Nucleic acids research.
[40] Jean Cadet,et al. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. , 2013, Cold Spring Harbor perspectives in biology.
[41] John A Kellum,et al. Acute kidney injury , 2012, The Lancet.
[42] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[43] Daniel G. Anderson,et al. Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.
[44] Hao Yan,et al. Interenzyme substrate diffusion for an enzyme cascade organized on spatially addressable DNA nanostructures. , 2012, Journal of the American Chemical Society.
[45] A. Singh,et al. Animal models of acute renal failure , 2012, Pharmacological reports : PR.
[46] Hao Yan,et al. Challenges and opportunities for structural DNA nanotechnology. , 2011, Nature nanotechnology.
[47] H. Pei,et al. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. , 2011, ACS nano.
[48] Yi Guo,et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging. , 2011, Journal of the American Chemical Society.
[49] Mark E. Davis,et al. Targeting kidney mesangium by nanoparticles of defined size , 2011, Proceedings of the National Academy of Sciences.
[50] D. Meldrum,et al. Stability of DNA origami nanoarrays in cell lysate. , 2011, Nano letters.
[51] Magnus Bergkvist,et al. Paradoxical glomerular filtration of carbon nanotubes , 2010, Proceedings of the National Academy of Sciences.
[52] N. Seeman. Nanomaterials based on DNA. , 2010, Annual review of biochemistry.
[53] Clare K. Carney,et al. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure , 2010, Proceedings of the National Academy of Sciences.
[54] M. Rosner,et al. Acute kidney injury. , 2009, Current drug targets.
[55] Jung-Won Keum,et al. Enhanced resistance of DNA nanostructures to enzymatic digestion. , 2009, Chemical communications.
[56] Neha Agnihotri,et al. Mechanism of scavenging action of N-acetylcysteine for the OH radical: a quantum computational study. , 2009, The journal of physical chemistry. B.
[57] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[58] P. Peduzzi,et al. Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.
[59] Ande Bao,et al. Dynamic Imaging of Functionalized Multi‐Walled Carbon Nanotube Systemic Circulation and Urinary Excretion , 2008 .
[60] S. Fishbane. N-acetylcysteine in the prevention of contrast-induced nephropathy. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[61] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[62] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[63] Volker Wagner,et al. The emerging nanomedicine landscape , 2006, Nature Biotechnology.
[64] P. Rothemund. Folding DNA to create nanoscale shapes and patterns , 2006, Nature.
[65] John A Kellum,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.
[66] K. Shyu,et al. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. , 2002, Journal of the American College of Cardiology.
[67] Y. Sugiyama,et al. Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[68] K. Nath,et al. Reactive oxygen species and acute renal failure. , 2000, The American journal of medicine.
[69] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[70] T. Hemnani,et al. Reactive oxygen species and oxidative DNA damage. , 1998, Indian journal of physiology and pharmacology.